CSOP MicroStrategy Daily (-2x) Inverse Product(07399.HK) rose 10.80% to HKD 32.220
Newtimespace News, as of 10:40 on April 30, CSOP MicroStrategy Daily (-2x) Inverse Product(07399.HK) was quoted at HKD 32.220, up 10.80%. The ETF opened at HKD 31.360, with a high of HKD 32.000 and a low of HKD 31.360. The latest trading volume was 35,300 units, with a turnover of HKD 1.1132 million, and a turnover rate of 5.02%. The latest NAV per unit is HKD 32.526, with a premium rate of -10.59%. The asset size is approximately HKD 22.8144 million, and the total issuance is 701,600 units.
CSOP MicroStrategy Daily (-2x) Inverse Product(07399.HK) is a leveraged inverse ETF product issued by CSOP Asset Management Limited. It aims to deliver returns equivalent to twice the inverse (-2x) of the daily return of the underlying asset (MicroStrategy Incorporated, MSTR). The product's investment strategy is primarily implemented through swap contracts and other financial derivatives. As a high-risk leveraged product, it is suitable for aggressive investors with a clear view on the short-term market direction. However, due to the daily reset mechanism and relatively high management fee, it is not suitable as a long-term holding asset.
NewTimeSpace Disclaimer: All content herein is the original work of NewTimeSpace. Any reproduction, reprinting, or use of this content in any other manner must clearly indicate the source as "NewTimeSpace". NewTimeSpace and its authorized third-party information providers strive to ensure the accuracy and reliability of the data, but do not guarantee the absolute correctness thereof. This content is for reference only and does not constitute any investment advice. All transaction risks shall be borne by the user.
- WAI CHUN BIOTEC (00660.HK): 2026 Annual Results May Be Delayed, Trading May Be Suspended
- SCIENTECH (02291.HK): Interim Revenue Down 5.9% to RMB 310.1 Million, Net Profit Down 19.5%
- LINMON MEDIA (09857.HK): Controlling Shareholder Gifts 23.22 Million Shares to Concert Parties and Key Staff
- C&D INTL GROUP (01908.HK): H1 Revenue RMB 17.80bn, Down 47.9%; Parent Profit RMB 825mn
- COFOE MEDICAL (01187.HK): Cuts A-share Buyback Price Cap to RMB 69.09/share After Interim Dividend